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Depression as a Risk
Factor for Post-MI Mortality
In a recent editorial, Lane et al. (1) conclude that depression is
probably not a risk factor for cardiac mortality. They assert that the
SADHART and ENRICHD trials were designed to determine
whether depression after myocardial infarction (MI) is causally
linked to clinical prognosis and that both trials failed to do so. In
fact, SADHART investigated the safety and efficacy of sertraline
in patients with recent MI or unstable angina (2). It was not
intended or powered to study the effects of depression treatment
on medical outcomes. The ENRICHD trial found no effect of
depression treatment on survival, but Lane et al. failed to mention
that there was only a small between-group difference in depression
outcomes (3). If a clinical trial of a cholesterol-lowering drug
produced little difference in cholesterol levels between the treat-
ment and control groups and no between-group difference in
survival, this finding would not justify demotion of cholesterol
from the ranks of major coronary risk factors. Similarly, the
ENRICHD findings do not negate the importance of depression
as a risk factor for post-MI mortality.
Lane et al. (1) claim that depression has predicted mortality
almost exclusively in studies in which it correlated with coronary
heart disease (CHD) severity at baseline. However, one of the
studies they cite to support this claim actually found that a
diagnosis of major depression was not related to CHD severity, but
was associated with an increased risk for six-month mortality (4).
Furthermore, in an ENRICHD ancillary study that included a
nondepressed comparison group, depression was not related to left
ventricular ejection fraction (LVEF), prior MI, or to Killip class
(4). The unadjusted hazard ratio (HR) was 2.8 (p  0.001) for
all-cause mortality. After adjusting for diabetes, smoking, LVEF,
prior MI, and other medical, demographic, and treatment variables
associated with mortality, the HR dropped only slightly to 2.4 (p
 0.02). Thus, depression was indeed a risk factor in the
ENRICHD trial. In studies in which depression has not predicted
survival, or has not remained an independent predictor after
covariate adjustment, inadequate statistical power has usually been
responsible. For example, one of the studies cited in the editorial
yielded a covariate-adjusted odds ratio of 4.9 for moderate to
severe depression that nevertheless was not statistically significant;
its sample included 560 patients but there were only 12 deaths (5).
It is not possible to measure or adjust for all possible risk factors
in any study. Furthermore, the measurement of any risk factor is
imperfect. Consequently, it can always be argued that an associa-
tion between nearly any risk factor and survival is due to “inade-
quate” covariate adjustment. However, researchers in this area have
adhered to the same rules of evidence as those investigating other
cardiovascular risk factors. The totality of evidence supports a
significant, independent influence of depression on cardiac mor-
tality.
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Is Depression a Risk Factor
for Coronary Heart Disease?
The editorial by Lane et al. (1), which cast doubt on the
relationship between depression and myocardial infarction (MI),
was inappropriately pessimistic and looked only at part of the
evidence. Their argument appears to be that in post-MI patients
any apparent relationship between depression and outcome is an
epiphenomenon and that the only causal relationship is between
disease severity and outcome. Certainly, if all we had were post-MI
data on which to base the “depression–heart disease” hypothesis,
our case would be weak because the potentially confounding effect
of an MI causing or exacerbating depression is hard to dismiss.
The strongest support for the hypothesis comes from a diverse
series of prospective studies showing that depression in asymptom-
atic and apparently healthy subjects is a strong and independent
predictor of MI. A recent meta-analysis identified 10 prospective
studies (2), where the overall relative risk for depression as an
independent risk factor for coronary events was 1.64, a risk
between that of passive smoking (n  1.25) and active smoking (n
 2.5). Nine of the 10 studies obtained positive results. Consid-
ering that depression is much harder to quantify than smoking
behavior (nine different measures of depression were used), that
depression was evaluated only once, and that the average follow-up
between the evaluation of depression and the outcome was on
average 13.6 years (up to 40 years in one case), this is a truly
impressive result.
The argument by Lane et al. that the reason why some of the
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